論文・技術情報追加のお知らせ

①Case Report: Collapsing Focal Segmental Glomerulosclerosis After Initiation of Ado-Trastuzumab Emtansine Therapy.

Ado-trastuzumab emtansine (T-DM1)の治療後腎臓有害事象症例報告

対象DB：FAERS

②Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System.

免疫チェックポイント阻害剤における消化器系の免疫関連有害事象調査研究

対象DB：FAERS

③Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study.

PCSK9阻害剤に伴う高血糖障害のファーマコビジランス研究

対象DB：FAERS

④The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system.

GLP-1受容体作動薬と糖尿病性ケトアシドーシスの関連性調査研究

対象DB：FAERS

⑤First case of DRESS syndrome caused by apalutamide, a novel oral androgen receptor antagonist.

アンドロゲン受容体拮抗薬アパルタミドによるDRESS症候群症例報告

対象DB：VigiBase

⑥Renal Safety Profile of EGFR Targeted Therapies: A Study from VigiBase((R)) the WHO Global Database of Individual Case Safety Reports.

EGFR標的治療薬の腎臓安全性プロファイル研究

対象DB：VigiBase